Mylan (NASDAQ:MYL) Shares Bought by Sompo Japan Nipponkoa Asset Management CO. LTD.

Sompo Japan Nipponkoa Asset Management CO. LTD. increased its stake in shares of Mylan (NASDAQ:MYL) by 61.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 148,170 shares of the company’s stock after purchasing an additional 56,350 shares during the quarter. Sompo Japan Nipponkoa Asset Management CO. LTD.’s holdings in Mylan were worth $6,269,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Crossmark Global Holdings Inc. raised its stake in Mylan by 78.2% in the fourth quarter. Crossmark Global Holdings Inc. now owns 32,140 shares of the company’s stock valued at $1,360,000 after buying an additional 14,100 shares during the last quarter. Public Employees Retirement Association of Colorado raised its stake in Mylan by 4.0% in the fourth quarter. Public Employees Retirement Association of Colorado now owns 88,816 shares of the company’s stock valued at $3,758,000 after buying an additional 3,400 shares during the last quarter. CIBC Asset Management Inc raised its stake in Mylan by 7.7% in the fourth quarter. CIBC Asset Management Inc now owns 53,201 shares of the company’s stock valued at $2,251,000 after buying an additional 3,802 shares during the last quarter. US Bancorp DE raised its stake in Mylan by 16.6% in the fourth quarter. US Bancorp DE now owns 1,214,438 shares of the company’s stock valued at $51,383,000 after buying an additional 173,112 shares during the last quarter. Finally, Aperio Group LLC raised its stake in Mylan by 199.5% in the fourth quarter. Aperio Group LLC now owns 292,018 shares of the company’s stock valued at $12,355,000 after buying an additional 194,510 shares during the last quarter. Hedge funds and other institutional investors own 75.56% of the company’s stock.

Shares of Mylan (MYL) opened at $40.41 on Wednesday. The company has a market capitalization of $21,779.31, a PE ratio of 25.10, a P/E/G ratio of 1.10 and a beta of 1.35. Mylan has a 1-year low of $29.39 and a 1-year high of $47.82. The company has a current ratio of 1.46, a quick ratio of 0.95 and a debt-to-equity ratio of 1.05.

In related news, CEO Heather M. Bresch sold 75,000 shares of the firm’s stock in a transaction dated Tuesday, January 9th. The stock was sold at an average price of $45.00, for a total transaction of $3,375,000.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.69% of the stock is owned by company insiders.

A number of research firms have commented on MYL. Zacks Investment Research upgraded Mylan from a “sell” rating to a “hold” rating in a research note on Tuesday, January 16th. Deutsche Bank set a $50.00 price target on Mylan and gave the company a “buy” rating in a research note on Wednesday, January 24th. Wells Fargo & Co set a $43.00 price target on Mylan and gave the company a “hold” rating in a research note on Thursday, January 18th. TheStreet upgraded Mylan from a “c” rating to a “b-” rating in a research note on Wednesday, January 17th. Finally, Susquehanna Bancshares reiterated a “positive” rating and issued a $55.00 price target (up from $47.00) on shares of Mylan in a research note on Thursday, January 25th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have issued a buy rating to the company’s stock. Mylan presently has a consensus rating of “Buy” and a consensus target price of $44.65.

ILLEGAL ACTIVITY NOTICE: This article was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this article on another publication, it was illegally copied and reposted in violation of United States & international copyright & trademark laws. The original version of this article can be read at https://www.dispatchtribunal.com/2018/02/14/sompo-japan-nipponkoa-asset-management-co-ltd-acquires-56350-shares-of-mylan-myl.html.

Mylan Company Profile

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.

Institutional Ownership by Quarter for Mylan (NASDAQ:MYL)

Receive News & Ratings for Mylan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply